Fletazepam
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.047.309 |
Chemical and physical data | |
Formula | C17H13ClF4N2 |
Molar mass | 356.75 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Fletazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, but is mainly notable for its strong muscle relaxant properties.[2]
Fletazepam is most closely related to other N-trifluoroethyl substituted benzodiazepines such as halazepam and quazepam.[3]
See also
[edit]References
[edit]- ^ DE 2106175, Steinmann, Martin, "Neue 1-Polyfluoralkylbenzodiazepine und Verfahren zu ihrer Herstellung [Novel 1-polyfluoroalkylbenzodiazepines and processes for their preparation]", published 1971-09-30, assigned to Sherico Ltd.
- ^ Barnett A, Goldstein J, Fiedler EP, Taber RI (November 1974). "The pharmacology of fletazepam a centrally-acting muscle relaxant". Archives Internationales de Pharmacodynamie et de Therapie. 212 (1): 164–74. PMID 4476200.
- ^ Iorio LC, Barnett A, Billard W (July 1984). "Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites". Life Sciences. 35 (1): 105–13. doi:10.1016/0024-3205(84)90157-7. PMID 6738302.